While TLR9 activation by CpG ODN has shown therapeutic promise in cancer immunotherapy and antimicrobial defense, its functional outcomes exhibit striking context-dependency, influenced by factors including ODN class, target cell type, and disease milieu. Here, TLR9 is linked to cancer.